Cargando…

Combination of dasabuvir and PSI-6206 for the treatment of coxsackievirus B3 infection

Coxsackievirus B3 (CVB3) infections may cause life-threatening diseases and have no approved specific treatment. Some promising approaches to treat viral diseases include drug repurposing and combination therapy. We have selected in this study dasabuvir, an approved antiviral drug, and PSI-6206, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olasunkanmi, Oluwatayo Israel, Zhong, Zhao-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249823/ https://www.ncbi.nlm.nih.gov/pubmed/35789934 http://dx.doi.org/10.1016/j.jve.2022.100074

Ejemplares similares

Novel Antiviral Activity of Ethyl 3-Hydroxyhexanoate Against Coxsackievirus B Infection
por: Olasunkanmi, Oluwatayo Israel, et al.
Publicado: (2022)

Virus-Induced Cytoplasmic Aggregates and Inclusions are Critical Cellular Regulatory and Antiviral Factors
por: Olasunkanmi, Oluwatayo Israel, et al.
Publicado: (2020)

Baseline dasabuvir resistance in Hepatitis C virus from the genotypes 1, 2 and 3 and modeling of the NS5B-dasabuvir complex by the in silico approach
por: Akaberi, Dario, et al.
Publicado: (2018)

Overexpression, purification, crystallization and data collection of Sulfolobus solfataricus Sso6206, a novel highly conserved protein
por: McEwan, Andrew R., et al.
Publicado: (2006)

Dasabuvir Inhibits Human Norovirus Infection in Human Intestinal Enteroids
por: Hayashi, Tsuyoshi, et al.
Publicado: (2021)

Coxsackievirus B3 infection reduces female mouse fertility
por: Shim, Hye Min, et al.
Publicado: (2015)

Real-world experience with ombitasvir/paritaprevir boosted with ritonavir and possibly combined with dasabuvir and ribavirin in HCV infection
por: Pogorzelska, Joanna, et al.
Publicado: (2016)

Antiviral and immunoregulatory effects of curcumin on coxsackievirus B3-infected hepatitis
por: Lin, Yu-Jheng, et al.
Publicado: (2023)

Paritaprevir/ritonavir-ombitasvir and dasabuvir, the 3D regimen for the treatment of chronic hepatitis C virus infection: a concise review
por: Hussaini, Trana
Publicado: (2016)

Cinnamaldehyde Derivatives Inhibit Coxsackievirus B3-Induced Viral Myocarditis
por: Li, Xiao-Qiang, et al.
Publicado: (2017)

Ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin for treatment of chronic hepatitis C 1 genotype in the Republic of Belarus
por: Danilau, Dzmitry, et al.
Publicado: (2017)

Coxsackievirus B Infection Is Highly Related with Missed Abortion in Korea
por: Hwang, Jung Hye, et al.
Publicado: (2014)

Profile of paritaprevir/ritonavir/ombitasvir plus dasabuvir in the treatment of chronic hepatitis C virus genotype 1 infection
por: Smith, Michael A, et al.
Publicado: (2015)

Coxsackievirus B3 infection induces glycolysis to facilitate viral replication
por: Qian, Yujie, et al.
Publicado: (2022)

Pyroptosis induced by enterovirus 71 and coxsackievirus B3 infection affects viral replication and host response
por: Wang, Yan, et al.
Publicado: (2018)

Pregnancy Loss Following Coxsackievirus B3 Infection in Mice during Early Gestation Due toHigh Expression of Coxsackievirus-Adenovirus Receptor (CAR) in Uterus and Embryo
por: Hwang, Ji Young, et al.
Publicado: (2014)

Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders
por: Fuchs, Michael, et al.
Publicado: (2020)

Pharmacokinetics and Dose Recommendations for Cyclosporine and Tacrolimus When Coadministered With ABT‐450, Ombitasvir, and Dasabuvir
por: Badri, P., et al.
Publicado: (2015)

Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease
por: Bernstein, David E., et al.
Publicado: (2018)

Clinical Features of Coxsackievirus A4, B3 and B4 Infections in Children
por: Lee, Chia-Jie, et al.
Publicado: (2014)

Protease 2A induces stress granule formation during coxsackievirus B3 and enterovirus 71 infections
por: Wu, Shuo, et al.
Publicado: (2014)

Antenatal diagnosis of intrauterine infection with coxsackievirus B3 associated with live birth.
por: Ouellet, Annie, et al.
Publicado: (2004)

Chromosome Y Regulates Survival Following Murine Coxsackievirus B3 Infection
por: Case, Laure K., et al.
Publicado: (2012)

Induction of cytopathic effect and cytokines in coxsackievirus B3-infected murine astrocytes
por: Zeng, Jun, et al.
Publicado: (2013)

Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3
por: Wang, Yao, et al.
Publicado: (2016)

Cell type-specific roles of PAR1 in Coxsackievirus B3 infection
por: Bode, Michael F., et al.
Publicado: (2021)

Ubiquitination Is Required for Effective Replication of Coxsackievirus B3
por: Si, Xiaoning, et al.
Publicado: (2008)

Inhibition of coxsackievirus B3 by RNA interference (RNAi)
por: Kurreck, J, et al.
Publicado: (2006)

Coxsackievirus B3—Its Potential as an Oncolytic Virus
por: Geisler, Anja, et al.
Publicado: (2021)

The antiviral effect of jiadifenoic acids C against coxsackievirus B3
por: Ge, Miao, et al.
Publicado: (2014)

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4
por: Leung, Daniel H., et al.
Publicado: (2018)

Inhibition of coxsackievirus infection in cardiomyocytes by small dsRNA targeting its cognate coxsackievirus adenovirus receptor
por: Sharma, Mirnalini, et al.
Publicado: (2017)

Coxsackievirus Infection and Associated Diseases
por: Nekoua, Magloire Pandoua, et al.
Publicado: (2022)

Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia
por: Forns, Xavier, et al.
Publicado: (2015)

Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel
por: Itkonen, Matti K., et al.
Publicado: (2018)

Ombitasvir/paritaprevir/ritonavir + dasabuvir +/- ribavirin in real world hepatitis C patients
por: Loo, Nicole, et al.
Publicado: (2019)

Protein 2B of Coxsackievirus B3 Induces Autophagy Relying on Its Transmembrane Hydrophobic Sequences
por: Wu, Heng, et al.
Publicado: (2016)

Specific elimination of coxsackievirus B3 infected cells with a protein engineered toxin-antitoxin system
por: Park, Jung-Ho, et al.
Publicado: (2019)

Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy
por: Hunyady, Béla, et al.
Publicado: (2018)

Pathogenesis of coxsackievirus B2 in mice: characterization of clinical isolates of the coxsackievirus B2 from patients with myocarditis and aseptic meningitis in Korea
por: Hong, Jiyoung, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sljinpachmnkldigtmd8e4adbv